Format
Sort by
Items per page

Send to

Choose Destination

Best matches for ovarian cancer AND (free full text[sb] AND:

Advances in tumor markers of ovarian cancer for early diagnosis. Dong X et al. Indian J Cancer. (2014)

Tumor infiltrating lymphocytes in ovarian cancer. Santoiemma PP et al. Cancer Biol Ther. (2015)

[Association between obesity and ovarian cancer]. Valladares M et al. Rev Med Chil. (2014)

Search results

Items: 1 to 20 of 29159

  • The following terms were ignored: (, AND
  • See the search details.
1.

Ovarian yolk sac tumor in postmenopausal females: A case series and a literature review.

Wang Y, Yang J, Yu M, Cao D, Zhang Y, Zong X, Shen K.

Medicine (Baltimore). 2018 Aug;97(33):e11838. doi: 10.1097/MD.0000000000011838.

2.

Fertility Preservation: Current and Future Perspectives for Oncologic Patients at Risk for Iatrogenic Premature Ovarian Insufficiency.

Pinelli S, Basile S.

Biomed Res Int. 2018 Jul 11;2018:6465903. doi: 10.1155/2018/6465903. eCollection 2018. Review.

3.

Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer.

Choi CH, Kang TH, Song JS, Kim YS, Chung EJ, Ylaya K, Kim S, Koh SS, Chung JY, Kim JH, Hewitt SM.

Sci Rep. 2018 Aug 15;8(1):12161. doi: 10.1038/s41598-018-30582-8.

4.

Rectal perforation following paclitaxel and carboplatin chemotherapy for advanced ovarian cancer: a case report and review of the literature.

Jayakody S, Wright DB, Chiong C, Liu M, Bouffler C, El-Khoury T.

J Med Case Rep. 2018 Aug 16;12(1):221. doi: 10.1186/s13256-018-1759-z.

5.

Immunhistochemical analysis of Nuclear Factor Kappa Beta expression in etiopathogenesis of ovarian tumors1.

Yilmaz E, Gul M, Melekoglu R, Koleli I.

Acta Cir Bras. 2018 Jul;33(7):641-650. doi: 10.1590/s0102-865020180070000009.

6.

Characterization and drug sensitivity of a novel human ovarian clear cell carcinoma cell line genomically and phenotypically similar to the original tumor.

Franklin M, Gentles L, Matheson E, Bown N, Cross P, Ralte A, Gilkes-Immeson C, Bradbury A, Zanjirband M, Lunec J, Drew Y, O'Donnell R, Curtin NJ.

Cancer Med. 2018 Aug 14. doi: 10.1002/cam4.1724. [Epub ahead of print]

7.

Standard and optimal cut-off values of serum ca-125, HE4 and ROMA in preoperative prediction of ovarian cancer in Vietnam.

Huy NVQ, Van Khoa V, Tam LM, Vinh TQ, Tung NS, Thanh CN, Chuang L.

Gynecol Oncol Rep. 2018 Jul 18;25:110-114. doi: 10.1016/j.gore.2018.07.002. eCollection 2018 Aug. Review.

8.

Zearalenone Exposure Enhanced the Expression of Tumorigenesis Genes in Donkey Granulosa Cells via the PTEN/PI3K/AKT Signaling Pathway.

Zhang GL, Song JL, Ji CL, Feng YL, Yu J, Nyachoti CM, Yang GS.

Front Genet. 2018 Jul 31;9:293. doi: 10.3389/fgene.2018.00293. eCollection 2018.

9.

Exosomal microRNAs as tumor markers in epithelial ovarian cancer.

Pan C, Stevic I, Müller V, Ni Q, Ferrer LO, Pantel K, Schwarzenbach H.

Mol Oncol. 2018 Aug 14. doi: 10.1002/1878-0261.12371. [Epub ahead of print]

10.

Correction: Optical imaging of ovarian cancer using a matrix metalloproteinase-3-sensitive near-infrared fluorescent probe.

Wang KH, Wang YM, Chiu LH, Chen TC, Tsai YH, Zuo CS, Chen KC, Changou CA, Lai WT.

PLoS One. 2018 Aug 14;13(8):e0202610. doi: 10.1371/journal.pone.0202610. eCollection 2018.

11.

BRCA1 and BRCA2 mutations and clinical interpretation in 398 ovarian cancer patients: comparison with breast cancer variants in a similar population.

Cardoso FC, Goncalves S, Mele PG, Liria NC, Sganga L, Diaz Perez I, Podesta EJ, Solano AR.

Hum Genomics. 2018 Aug 13;12(1):39. doi: 10.1186/s40246-018-0171-5.

12.

Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care.

Silverman TB, Vanegas A, Marte A, Mata J, Sin M, Ramirez JCR, Tsai WY, Crew KD, Kukafka R.

BMC Health Serv Res. 2018 Aug 13;18(1):633. doi: 10.1186/s12913-018-3442-x.

13.

Targeting the Microenvironment in High Grade Serous Ovarian Cancer.

Nwani NG, Sima LE, Nieves-Neira W, Matei D.

Cancers (Basel). 2018 Aug 10;10(8). pii: E266. doi: 10.3390/cancers10080266. Review.

14.

Quantitative Analysis of BRCA1 and BRCA2 Germline Splicing Variants Using a Novel RNA-Massively Parallel Sequencing Assay.

Farber-Katz S, Hsuan V, Wu S, Landrith T, Vuong H, Xu D, Li B, Hoo J, Lam S, Nashed S, Toppmeyer D, Gray P, Haynes G, Lu HM, Elliott A, Tippin Davis B, Karam R.

Front Oncol. 2018 Jul 27;8:286. doi: 10.3389/fonc.2018.00286. eCollection 2018.

15.

Ultrasound-guided intranodal lymphangiography with lipiodol for treatment of chylous ascites following surgery for ovarian cancer: A case report.

Nakamura K, Nakayama K, Minamoto T, Ishibashi T, Ohnishi K, Yamashita H, Ono R, Sasamori H, Razia S, Kamrunnahar S, Ishikawa M, Kyo S.

Mol Clin Oncol. 2018 Aug;9(2):178-180. doi: 10.3892/mco.2018.1647. Epub 2018 Jun 8.

16.

Correction: Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice.

Reeves PM, Abbaslou MA, Kools FRW, Vutipongsatorn K, Tong X, Gavegnano C, Schinazi RF, Poznansky MC.

Oncotarget. 2018 Jul 13;9(54):30472. doi: 10.18632/oncotarget.25791. eCollection 2018 Jul 13.

17.

FAM98A promotes proliferation of non-small cell lung cancer cells via the P38-ATF2 signaling pathway.

Zheng R, Liu Q, Wang T, Wang L, Zhang Y.

Cancer Manag Res. 2018 Jul 27;10:2269-2278. doi: 10.2147/CMAR.S163323. eCollection 2018.

18.

LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression.

Liang H, Yu T, Han Y, Jiang H, Wang C, You T, Zhao X, Shan H, Yang R, Yang L, Shan H, Gu Y.

Mol Cancer. 2018 Aug 11;17(1):119. doi: 10.1186/s12943-018-0870-5.

19.

Clinical benefit of controversial first line systemic therapies for advanced stage ovarian cancer - ESMO-MCBS scores.

Broekman KE, Jalving M, van Tinteren H, Sessa C, Reyners AKL.

Cancer Treat Rev. 2018 Jun 18;69:233-242. doi: 10.1016/j.ctrv.2018.06.008. [Epub ahead of print] Review.

20.

Organotypic 3D Models of the Ovarian Cancer Tumor Microenvironment.

Watters KM, Bajwa P, Kenny HA.

Cancers (Basel). 2018 Aug 9;10(8). pii: E265. doi: 10.3390/cancers10080265. Review.

Supplemental Content

Loading ...
Support Center